Clal Biotechnology | CBI - Sales Revenues


Clal Biotechnology reported ILS3.41M in Sales Revenues for its fiscal quarter ending in December of 2022.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 110.08M 109.89M Dec/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 67.33M 65.44M Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
RedHill Biopharma USD 1.29M 722K Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024